Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 17.47% is 68% above its 5-year average of 10.42%, around the middle of its 5-year range (3.01%–25.70%).
2.07% above its 12-month average of 17.12%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 16.67%.
NET PROFIT MARGIN
17.47%
NET PROFIT MARGIN AVG TTM
17.12%
NET PROFIT MARGIN AVG 3Y
13.85%
NET PROFIT MARGIN AVG 5Y
10.42%
NET PROFIT MARGIN AVG 10Y
10.58%
NET PROFIT MARGIN AVG 15Y
7.68%
NET PROFIT MARGIN AVG 20Y
7.14%
CURRENT VS TTM AVG
+2.07%
CURRENT VS 3Y AVG
+26.12%
CURRENT VS 5Y AVG
+67.64%
CURRENT VS 10Y AVG
+65.19%
CURRENT VS 15Y AVG
+127.56%
CURRENT VS 20Y AVG
+144.54%
SECTOR MEDIAN · HEALTHCARE
9.21%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+89.79%
vs the sector median at left
Boston Scientific Corporation
Market Cap
$64.08B
Net Profit Margin
17.47%
TTM Avg
17.12%
3Y Avg
13.85%
5Y Avg
10.42%
Market Cap
$62.86B
Net Profit Margin
-141.43%
TTM Avg
-128.24%
3Y Avg
-70.25%
5Y Avg
-50.87%
Market Cap
$53.42B
Net Profit Margin
0.67%
TTM Avg
0.69%
3Y Avg
0.48%
5Y Avg
0.29%
Market Cap
$51.08B
Net Profit Margin
15.43%
TTM Avg
47.22%
3Y Avg
37.68%
5Y Avg
33.03%
Market Cap
$50.55B
Net Profit Margin
4.52%
TTM Avg
8.06%
3Y Avg
8.30%
5Y Avg
8.27%
Market Cap
$80.63B
Net Profit Margin
27.86%
TTM Avg
31.24%
3Y Avg
32.06%
5Y Avg
36.64%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Boston Scientific Corporation (BSX) | $64.08B | 17.47% | 17.12% | 13.85% | 10.42% |
| Moderna, Inc. (MRNA)vs › | $62.86B | -141.43% | -128.24% | -70.25% | -50.87% |
| Cencora, Inc. (COR)vs › | $60.89B | 0.79% | 0.49% | 0.59% | 0.22% |
| Cigna Corporation (CI)vs › | $73.35B | 2.27% | 1.78% | 2.48% | 3.04% |
| Cardinal Health, Inc. (CAH)vs › | $53.42B | 0.67% | 0.69% | 0.48% | 0.29% |
| Edwards Lifesciences Corporation (EW)vs › | $51.08B | 15.43% | 47.22% | 37.68% | 33.03% |
| Becton, Dickinson and Company (BDX)vs › | $50.55B | 4.52% | 8.06% | 8.30% | 8.27% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $80.63B | 27.86% | 31.24% | 32.06% | 36.64% |
| Humana Inc. (HUM)vs › | $46.06B | 0.88% | 0.97% | 1.82% | 2.53% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $45.95B | 4.08% | -0.87% | -5.42% | -7.16% |
Operating Margin
21.5%
Net Profit Margin
17.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 16.67% |
| 2026-03-31 | 25.70% |
| 2025-12-31 | 12.64% |
| 2025-09-30 | 14.91% |
| 2025-06-30 | 15.67% |
| 2025-03-31 | 14.45% |
| 2024-12-31 | 12.41% |
| 2024-09-30 | 11.14% |
| 2024-06-30 | 7.86% |
| 2024-03-31 | 12.81% |
| 2023-12-31 | 13.53% |
| 2023-09-30 | 14.29% |
| 2023-06-30 | 7.50% |
| 2023-03-31 | 9.27% |
| 2022-12-31 | 4.32% |
| 2022-09-30 | 5.93% |
| 2022-06-30 | 8.01% |
| 2022-03-31 | 3.67% |
| 2021-12-31 | 3.01% |
| 2021-09-30 | 14.29% |
| 2021-06-30 | 6.04% |
| 2021-03-31 | 12.39% |
| 2020-12-31 | 5.61% |
| 2020-09-30 | -5.83% |
| 2020-06-30 | -7.34% |
| 2020-03-31 | 0.43% |
| 2019-12-31 | 137.56% |
| 2019-09-30 | 4.65% |
| 2019-06-30 | 5.85% |
| 2019-03-31 | 17.01% |
| 2018-12-31 | 15.07% |
| 2018-09-30 | 18.05% |
| 2018-06-30 | 22.29% |
| 2018-03-31 | 12.53% |
| 2017-12-31 | -25.54% |
| 2017-09-30 | 12.74% |
| 2017-06-30 | 6.47% |
| 2017-03-31 | 13.43% |
| 2016-12-31 | 5.66% |
| 2016-09-30 | 10.83% |
| 2016-06-30 | -9.74% |
| 2016-03-31 | 10.29% |
| 2015-12-31 | -7.18% |
| 2015-09-30 | -10.49% |
| 2015-06-30 | 5.53% |
| 2015-03-31 | -0.06% |
| 2014-12-31 | 4.61% |
| 2014-09-30 | 2.33% |
| 2014-06-30 | 0.21% |
| 2014-03-31 | 7.50% |
| 2013-12-31 | 5.88% |
| 2013-09-30 | -0.29% |
| 2013-06-30 | 7.19% |
| 2013-03-31 | -20.10% |
| 2012-12-31 | 3.35% |
| 2012-09-30 | -41.79% |
| 2012-06-30 | -186.21% |
| 2012-03-31 | 6.06% |
| 2011-12-31 | 5.79% |
| 2011-09-30 | 7.58% |
| 2011-06-30 | 7.39% |
| 2011-03-31 | 1.04% |
| 2010-12-31 | 11.79% |
| 2010-09-30 | 9.92% |
| 2010-06-30 | 5.08% |
| 2010-03-31 | -81.07% |
| 2009-12-31 | -51.76% |
| 2009-09-30 | 9.88% |
| 2009-06-30 | 7.62% |
| 2009-03-31 | -0.65% |
| 2008-12-31 | -119.58% |
| 2008-09-30 | -3.13% |
| 2008-06-30 | 4.84% |
| 2008-03-31 | 15.74% |
| 2007-12-31 | -21.27% |
| 2007-09-30 | -13.28% |
| 2007-06-30 | 5.55% |
| 2007-03-31 | 5.75% |
| 2006-12-31 | 13.41% |
| 2006-09-30 | 3.75% |
| 2006-06-30 | -201.99% |
| 2006-03-31 | 20.49% |
| 2005-12-31 | 21.69% |
| 2005-09-30 | -17.80% |
| 2005-06-30 | 12.68% |
| 2005-03-31 | 22.17% |
| 2004-12-31 | 18.56% |
| 2004-09-30 | 17.41% |
| 2004-06-30 | 21.44% |
| 2004-03-31 | 17.93% |
| 2003-12-31 | 14.59% |
| 2003-09-30 | 14.16% |
| 2003-06-30 | 13.35% |
| 2003-03-31 | 12.02% |
| 2002-12-31 | 12.90% |
| 2002-09-30 | 22.30% |
